GVM ±R in Patients With Relapsed or Refractory Aggressive NHL.

Conditions: Peripheral T Cell Lymphoma; Diffuse Large B-cell Lymphoma Interventions: Drug: GVM ±R regimen Sponsors: Qiu Lugui Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials